Drug Shortage Report for APO-OLOPATADINE
| Report ID | 82016 |
| Drug Identification Number | 02305054 |
| Brand name | APO-OLOPATADINE |
| Common or Proper name | OLOPATADINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OLOPATADINE |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01GX |
| ATC description | DECONGESTANTS AND ANTIALLERGICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-15 |
| Estimated end date | 2019-06-28 |
| Actual end date | 2019-06-21 |
| Shortage status | Resolved |
| Updated date | 2019-06-24 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.